Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

Inclusion Criteria:

• Primary diagnosis of BED according to DSM-5 criteria.

• Provides written informed consent to participate in the study before the conduct ofany study procedures.

• Male or female, aged 18 to 55 inclusive.

Exclusion Criteria:

• Prior exposure to solriamfetol/Sunosi, through either a clinical study orprescription.

• Unable to comply with study procedures.

• Medically inappropriate for study participation in the opinion of the investigator.